Fasting and Physical Activity on GLP-1 Drugs: Impact on Weight Loss Motivation

Study examines how fasting impacts physical activity motivation and weight reduction in patients on GLP-1 drugs, with implications for optimizing lifestyle during treatment.

Almaqhawi, Abdullah et al.·Patient preference and adherence·2025·Preliminary Evidencecohort
RPEP-09882CohortPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
cohort
Evidence
Preliminary Evidence
Sample
N=small
Participants
Adults using GLP-1 drugs (semaglutide/tirzepatide) during Ramadan 2024 in Saudi Arabia

What This Study Found

Study examines how fasting impacts physical activity motivation and weight reduction in patients on GLP-1 drugs, with implications for optimizing lifestyle during treatment.

Key Numbers

Qualitative study conducted during and after Ramadan 2024 at a Saudi Arabian university clinic.

How They Did This

Methodology detailed in publication.

Why This Research Matters

Relevant to expanding peptide-based therapeutic applications.

The Bigger Picture

Contributes to the growing evidence for peptide therapeutics.

What This Study Doesn't Tell Us

Limitations in publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to existing evidence?
  • ?Next research steps?

Trust & Context

Key Stat:
Key finding Study examines how fasting impacts physical activity motivation and weight reduction in patients on
Evidence Grade:
Based on study design in publication.
Study Age:
Published in 2025.
Original Title:
Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.
Published In:
Patient preference and adherence, 19, 19-28 (2025)
Database ID:
RPEP-09882

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What does this mean?

Study examines how fasting impacts physical activity motivation and weight reduction in patients on GLP-1 drugs, with implications for optimizing lifestyle during treatment.

How reliable?

Consult publication and healthcare provider.

Read More on RethinkPeptides

Cite This Study

RPEP-09882·https://rethinkpeptides.com/research/RPEP-09882

APA

Almaqhawi, Abdullah; Alabdulqader, Razan Anwar; Alkhteeb, Nurah Abdullatef; Alomair, Fai Ibrahim; Alhassan, Sarra Riyadh; Alnajjar, Jawad S. (2025). Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.. Patient preference and adherence, 19, 19-28. https://doi.org/10.2147/PPA.S496613

MLA

Almaqhawi, Abdullah, et al. "Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.." Patient preference and adherence, 2025. https://doi.org/10.2147/PPA.S496613

RethinkPeptides

RethinkPeptides Research Database. "Impact of Fasting on Physical Activity Motivation and Weight..." RPEP-09882. Retrieved from https://rethinkpeptides.com/research/almaqhawi-2025-impact-of-fasting-on

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.